John Somberg to Middle Aged
This is a "connection" page, showing publications John Somberg has written about Middle Aged.
Connection Strength
0.541
-
The Efficacy of Nitric Oxide-Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patients of African American and Hispanic Origin. Am J Med. 2023 10; 136(10):1035-1040.e11.
Score: 0.089
-
QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol. Cardiology. 2010; 116(3):219-25.
Score: 0.036
-
Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72.
Score: 0.036
-
Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006; 106(4):224-32.
Score: 0.027
-
Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004 Mar 01; 93(5):576-81.
Score: 0.023
-
Enhancement of myocardial vulnerability by atrial fibrillation. Am J Ther. 2004 Jan-Feb; 11(1):33-43.
Score: 0.023
-
The quest for an aqueous amiodarone. Am J Ther. 2003 Nov-Dec; 10(6):458-61.
Score: 0.023
-
Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22.
Score: 0.019
-
Clinical therapeutic conference: congestive heart failure therapy. Am J Ther. 2001 Jan-Feb; 8(1):65-72.
Score: 0.019
-
Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. Am Heart J. 1998 Mar; 135(3):519-22.
Score: 0.015
-
QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment. Am J Cardiol. 1997 May 01; 79(9):1190-3.
Score: 0.014
-
Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 1997 Feb 15; 79(4):508-11.
Score: 0.014
-
Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia? Am J Cardiol. 1995 Aug 15; 76(5):337-9.
Score: 0.013
-
A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil. Acta Anaesthesiol Scand Suppl. 1993; 99:43-7.
Score: 0.011
-
A comparison of tablets with oral suspension formulation of dipyridamole in thallium myocardial imaging. J Clin Pharmacol. 1992 Jun; 32(6):546-52.
Score: 0.010
-
The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
Score: 0.007
-
Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
Score: 0.007
-
Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25.
Score: 0.007
-
Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
Score: 0.007
-
Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5.
Score: 0.007
-
Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6.
Score: 0.007
-
Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
Score: 0.007
-
Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
Score: 0.007
-
Prophylactic tocainide or lidocaine in acute myocardial infarction. Am J Cardiol. 1986 Mar 01; 57(8):527-31.
Score: 0.007
-
QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
Score: 0.007
-
Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81.
Score: 0.007
-
The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24.
Score: 0.006
-
The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7.
Score: 0.006
-
Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33.
Score: 0.006
-
Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
Score: 0.006
-
Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27.
Score: 0.006
-
Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.
Score: 0.006
-
Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
Score: 0.006
-
Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
Score: 0.006
-
Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
Score: 0.006
-
Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B.
Score: 0.006
-
Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6.
Score: 0.006
-
Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43.
Score: 0.006
-
Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol. 2000 Apr; 20(2):260-4.
Score: 0.004
-
Lithium, hypercalcemia, and arrhythmia. J Clin Psychopharmacol. 1998 Oct; 18(5):420-3.
Score: 0.004
-
Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F.
Score: 0.002
-
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
Score: 0.002
-
Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62.
Score: 0.002
-
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
Score: 0.002
-
Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
Score: 0.002
-
Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16.
Score: 0.001
-
Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. N Y State J Med. 1978 May; 78(6):888-9.
Score: 0.001